Deaggregation of human platelets in vitro by an RGD analog antagonist of platelet glycoprotein IIb/IIIa receptors
- 30 November 1989
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 56 (6) , 687-695
- https://doi.org/10.1016/0049-3848(89)90286-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.Circulation, 1989
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988
- Platelets and Antiplatelet Therapy in Ischemic Heart DiseaseMedical Clinics of North America, 1988
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Circulating aggregated platelets in coronary artery diseaseThe American Journal of Cardiology, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.Circulation, 1985
- Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptorBlood, 1985
- Disaggregation and reaggregation of ‘irreversibly’ aggregated platelets: A method for more complete evaluation of anti-platelet drugsInflammation Research, 1985